Ishiguro, Susumu <br/><br/>
Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.  [electronic resource] 

 -  Biochemical and biophysical research communications  01 2018 
 - 962-968 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2017.11.102  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred C57BL<br/>Pancreatic Neoplasms--drug therapy<br/>Peptide Fragments--administration & dosage<br/>Protein Kinase C--administration & dosage<br/>T-Lymphocytes--drug effects<br/>Gemcitabine